CD4 and ductal breast carcinoma in situ: Thus, in this study, we examined infiltrations of CD4+, CD8+, and FOXP3+ TILs and PD-L1+ immune cells in DCIS in relation to clinicopathologic features and compared them with those of invasive breast cancer to evaluate their changes during progression of DCIS.